Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

711 Results

Regimen

PEMI

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

pemigatinib (Unfunded)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Jun 2022

Document

Screening-and-Management-of-Hep-B.pdf

Aug 2022

Document

Screening-and-Management-of-Hep-B_FR.pdf

Aug 2022

Document

SCO2022donnees-FR

Aug 2022

Guidelines and Advice

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Status: In-Review
ID: GL END 3-24

Aug 2022

Document

PanCanadianReviewProcess.png

Nov 2022

Document

PanCanadianReviewProcess-FR.png

Nov 2022

Statistical Reports

Prevention System Quality Index: Special Report on Cancer Prevention for People Living with Serious Mental Illness

Document

SelectedCancerRiskAmongFirefighters.png

Nov 2022

Document

SelectedCancerRiskAmongFirefighters-FR.png

Nov 2022

Document

Statistiques-sur-le-cancer-en-Ontario-2022.pdf

Nov 2022

Document

SpecialReportCancerPreventionPeopleLivingSeriousMentalIllness.pdf

Dec 2022

Pages